Tinea imbricata - Clinicals, Diagnosis, and Management

Dermatology

Clinicals - History

Fact Explanation
Multiple concentric rings of papules with scales over the body surface Tinea imbricata is a superficial dermatophyte fungal infection. It is caused by fungi of human sources (anthrophilic organisms). The commonest causative organism is Trichophyton concentricum. ,,,, Multiple concentric rings of papules with scales over the body surface
Tinea imbricata is a superficial dermatophyte fungal infection. It is caused by fungi of human sources (anthrophilic organisms). The commonest causative organism is Trichophyton concentricum. ,,,,
Pruritus Most of patients complain of pruritus, It may range from mild to intense itching. ,,, Pruritus
Most of patients complain of pruritus, It may range from mild to intense itching. ,,,
Contact history Tinea imbricata is a contagious and communicable fungal infection. Therefore contact history with infected family member of sharing clothes, towels, bed linen may be positive. Overcrowding and poor social conditions are other risk factors. , Contact history
Tinea imbricata is a contagious and communicable fungal infection. Therefore contact history with infected family member of sharing clothes, towels, bed linen may be positive. Overcrowding and poor social conditions are other risk factors. ,
History of immune suppression Protection against fungal infection is mediated by the cell mediated immunity (CMI). Long term steroid therapy, Cushing syndrome, malnutrition and HIV infection may be positive in the history. ,,, History of immune suppression
Protection against fungal infection is mediated by the cell mediated immunity (CMI). Long term steroid therapy, Cushing syndrome, malnutrition and HIV infection may be positive in the history. ,,,
History of living in endemic regions. Tinea imbricata is endemic in some islands of the South Pacific (Polynesia), South-East Asia, Central and South America, and Mexico. High humidity and warmth provide a favorable environment for the growth of causative fungal organisms. History of living in endemic regions.
Tinea imbricata is endemic in some islands of the South Pacific (Polynesia), South-East Asia, Central and South America, and Mexico. High humidity and warmth provide a favorable environment for the growth of causative fungal organisms.

Clinicals - Examination

Fact Explanation
Multiple erythematous scaly circular ring like papule involving the skin of extensor surface of arm, trunk and limbs. Tinea imbricata is a superficial, dermatophyte fungal infection. Dermatophyte lesions appear because of delayed or type-4 hypersensitivity reaction to the Trichophyton concentricum cytoplasmic antigen. ,,,, Multiple erythematous scaly circular ring like papule involving the skin of extensor surface of arm, trunk and limbs.
Tinea imbricata is a superficial, dermatophyte fungal infection. Dermatophyte lesions appear because of delayed or type-4 hypersensitivity reaction to the Trichophyton concentricum cytoplasmic antigen. ,,,,
Small vesicles and pustules may be seen within the lesions. Small vesicles and pustules may be seen within the lesions, specially in the advancing margin due to the acute inflammation. Fungi from human sources (anthrophilic organisms) cause lesions with minimal inflammation. , Small vesicles and pustules may be seen within the lesions.
Small vesicles and pustules may be seen within the lesions, specially in the advancing margin due to the acute inflammation. Fungi from human sources (anthrophilic organisms) cause lesions with minimal inflammation. ,
Erythema most pronounced at the periphery Due to acute inflammation in advancing margin, erythema most pronounced at the periphery. The lesions expand slowly and healed areas have a typical ring like pattern. , Erythema most pronounced at the periphery
Due to acute inflammation in advancing margin, erythema most pronounced at the periphery. The lesions expand slowly and healed areas have a typical ring like pattern. ,

Investigations - Diagnosis

Fact Explanation
Woods light examination Uses ultraviolet light to observe skin closely. It reveals some of the epidermophytes with green fluorescence. But some causative fungus does not fluorescence. ,, Woods light examination
Uses ultraviolet light to observe skin closely. It reveals some of the epidermophytes with green fluorescence. But some causative fungus does not fluorescence. ,,
Light microscopic examination The skin scrapings should be taken from the scaly margin of a lesion, with a small curette or a scalpel blade. The specimens are cleared in pottassium hydroxide. Branching hyphae and spores can easily be seen. ,, Light microscopic examination
The skin scrapings should be taken from the scaly margin of a lesion, with a small curette or a scalpel blade. The specimens are cleared in pottassium hydroxide. Branching hyphae and spores can easily be seen. ,,
Culture Culture should be carried out in a mycology or bacteriology laboratory. Transport medium is not necessary, and specimens can be sent in folded black paper and dry petri dish. The report may take as long as a month: microscopy is much quicker. ,, Culture
Culture should be carried out in a mycology or bacteriology laboratory. Transport medium is not necessary, and specimens can be sent in folded black paper and dry petri dish. The report may take as long as a month: microscopy is much quicker. ,,

Investigations - Management

Fact Explanation
Periodic monitoring These patients are given systemic anti fungals. Periodically assessment of response to therapy and side effects must be monitored because of the possibility of serious hepatotoxicity and occurrence of other side effects, including Thrombocytopenia. Therefore periodically Liver functions and full blood count assessment is important., Periodic monitoring
These patients are given systemic anti fungals. Periodically assessment of response to therapy and side effects must be monitored because of the possibility of serious hepatotoxicity and occurrence of other side effects, including Thrombocytopenia. Therefore periodically Liver functions and full blood count assessment is important.,

Management - Supportive

Fact Explanation
Educate the patient Tinea imbricata is a superficial fungal infection which can be treated successfully. ,,, Educate the patient
Tinea imbricata is a superficial fungal infection which can be treated successfully. ,,,
Advise regarding hygiene Tinea imbricata is a contagious and communicable fungal infection. Therefore advise not to share clothes, towels, bedlinen etc. Advise regarding importance of daily bathing and wearing clean,dry clothes. ,,, Advise regarding hygiene
Tinea imbricata is a contagious and communicable fungal infection. Therefore advise not to share clothes, towels, bedlinen etc. Advise regarding importance of daily bathing and wearing clean,dry clothes. ,,,

Management - Specific

Fact Explanation
Local imidazole preparations An imidazole containing preparation (such as miconazole, econazole and clotrimazole) used twise daily for 3-4 week period. Imidazoles interfere with fungal oxidative enzymes to cause lethal accumulation of hydrogen peroxide. They also reduce the formation of ergosterol, an important constituent of fungal cell wall which thus becomes permeable to intracellular constituents. Usually topical treatment alone inadequate. Therefore systemic drugs needs to be considered from the beginning. ,,,, Local imidazole preparations
An imidazole containing preparation (such as miconazole, econazole and clotrimazole) used twise daily for 3-4 week period. Imidazoles interfere with fungal oxidative enzymes to cause lethal accumulation of hydrogen peroxide. They also reduce the formation of ergosterol, an important constituent of fungal cell wall which thus becomes permeable to intracellular constituents. Usually topical treatment alone inadequate. Therefore systemic drugs needs to be considered from the beginning. ,,,,
Terbinafin Has now largely superseded griseofulvin. It acts by inhibiting fungal squalaneepoxidase and does not interact with cytochrome p-450 system. It is fungicidal and so cures chronic dermatophyte infections more quickly and more reliably than griseofulvin. 250mg daily given for2-6 weeks. ,,, Terbinafin
Has now largely superseded griseofulvin. It acts by inhibiting fungal squalaneepoxidase and does not interact with cytochrome p-450 system. It is fungicidal and so cures chronic dermatophyte infections more quickly and more reliably than griseofulvin. 250mg daily given for2-6 weeks. ,,,
Itraconazole Is now preferred to Ketoconazole , which occasionally damages the liver, and is a reasonable alternative to terbinafin if this is contraindicated. Fungistactic rather than fungicidal, it interferes with cytochrome P-450 system, so a review of any other medication being taken is needed before a prescription is issued. ,,, Itraconazole
Is now preferred to Ketoconazole , which occasionally damages the liver, and is a reasonable alternative to terbinafin if this is contraindicated. Fungistactic rather than fungicidal, it interferes with cytochrome P-450 system, so a review of any other medication being taken is needed before a prescription is issued. ,,,
Ketoconazole This drug should be reserved for patients with severe and resistant disease because of the possibility of serious hepatotoxicity and occurrence of other side effects, including rashes, Thrombocytopenia and gastrointestinal disturbances. 200mg daily given for 2-6weeks. ,,, Ketoconazole
This drug should be reserved for patients with severe and resistant disease because of the possibility of serious hepatotoxicity and occurrence of other side effects, including rashes, Thrombocytopenia and gastrointestinal disturbances. 200mg daily given for 2-6weeks. ,,,
Griseofulvin Was for many years drug of choice for chronic dermatophyte infections, but is now largely reserved for treatment of Tinea capitis. Griseofulvin prevents fungal growth by inhibiting mitosis. The therapeutic efficacy of griseofulvin depends on its capacity to bind to keratin. ,,, Griseofulvin
Was for many years drug of choice for chronic dermatophyte infections, but is now largely reserved for treatment of Tinea capitis. Griseofulvin prevents fungal growth by inhibiting mitosis. The therapeutic efficacy of griseofulvin depends on its capacity to bind to keratin. ,,,

Concise, fact-based medical articles to refresh your knowledge

Access a wealth of content and skim through a smartly presented catalog of diseases and conditions.

  1. BENNET, P.N. and BROWN, M.J. CLINICAL PHARMACOLOGY. 9th Ed. CHURCHILL LIVINGSTONE. 2003, 263-267.
  2. KATZUNG, Bertram G. MASTERS, Susan B. and TREVOR, Anthony J. Basic and Clinical Pharmacology. 12th Ed. Tata McGraw-Hill. 2012, 849-860.
  3. KUMAR, Parveen and CLARK, Michael. KUMAR & CLARK'S Clinical Medicine. 8th Ed. ELSEVIER. 2012,1200-1201.
  4. KUMAR, Parveen and CLARK, Michael. KUMAR & CLARK'S Clinical Medicine. 8th Ed. ELSEVIER. 2012,1200-1201.
  5. KUMAR, Parveen and CLARK, Michael. KUMAR & CLARK'S Clinical Medicine. 8th Ed. ELSEVIER. 2012,1200-1201.
  6. MARKS JR, James G. and MILLER Jeffery. Lookilgbill& Marks’ Principles of Dermatology. 4th Ed. Elesvier. 2006,125-128.
  7. MARKS JR, James G. and MILLER Jeffery. Lookilgbill& Marks’ Principles of Dermatology. 4thEd. Elesvier. 2006,125-128.
  8. MARKS JR, James G. and MILLER Jeffery. Lookilgbill& Marks’ Principles of Dermatology. 4thEd. Elesvier. 2006,125-128.
  9. MARKS, Ronald. ROXBURGH'S Common Skin Diseases. 17th Ed. Arnold Publishers. 2003, 39-43.
  10. MARKS, Ronald. ROXBURGH'S Common Skin Diseases. 17th Ed. Arnold Publishers. 2003, 39-43.
  11. MARKS, Ronald. ROXBURGH'S Common Skin Diseases. 17th Ed. Arnold Publishers. 2003, 39-43.
  12. MARKS, Ronald. ROXBURGH'S Common Skin Diseases. 17th Ed. Arnold Publishers. 2003, 39-43.
  13. MARKS, Ronald. ROXBURGH'S Common Skin Diseases. 17th Ed. Arnold Publishers. 2003, 39-43.
  14. MARKS, Ronald. ROXBURGH'S Common Skin Diseases. 17th Ed. Arnold Publishers. 2003, 39-43.
  15. MOUSAVI, Seyyed Amin Ayatollahi. SARDOIP, Sammira salari. SHAMSADINI, Sadollah. A First case of tinea imbricata from Iran. Jundishpur Journal of microbiology (2009);2920:71-74. [Viewed on 21.05.2014] Available from:http://www.jjmicrobiol.com/5726.pdf
  16. MOUSAVI, Seyyed Amin Ayatollahi. SARDOIP, Sammira salari. SHAMSADINI, Sadollah. A First case of tinea imbricata from Iran. Jundishpur Journal of microbiology (2009);2920:71-74. [Viewed on 21.05.2014] Available from:http://www.jjmicrobiol.com/5726.pdf
  17. NARANG, Kirti. PAHWA, Manish and RAMESH, V. Tinea Capitis in the form of Concentric Rings in an HIV Positive Adult on Antiretroviral Treatment. Indian J Dermatol. 2012 Jul-Aug; 57(4): 288–290. [Viewed on 21.05.2014] doi: 10.4103/0019-5154.97672 Available from:http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3401845/
  18. NARANG, Kirti. PAHWA, Manish and RAMESH, V. Tinea Capitis in the form of Concentric Rings in an HIV Positive Adult on Antiretroviral Treatment. Indian J Dermatol. 2012 Jul-Aug; 57(4): 288–290. [Viewed on 21.05.2014] doi: 10.4103/0019-5154.97672 Available from:http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3401845/
  19. QADIM, H.H. GOLFOROUSHAN, F. AZIMI, H. and Goldust, M. Factors leading to dermatophytosis. Annals of parasitology. 2013;59(2):99-102. [Viewed on 21.05.2014]
  20. RAO, A.G. Datta, N. Tinea corporis due to Trichophyton mentagrophytes and Trichophyton tonsurans mimicking tinea imbricata. Indian J Dermatol Venereol Leprol [Online] 2013;79:554. [Viewed on 2014.05.21] Available from: http://www.ijdvl.com/text.asp?2013/79/4/554/113109
  21. WELLER, Richard P.J.B. HUNTER, John A.A. SAVIN, John A. and DAHL, Mark V. Clinical Dermatology. 4th Ed. Blackwell publishing. 2008, 248-252.
  22. WELLER, Richard P.J.B. HUNTER, John A.A. SAVIN, John A. and DAHL, Mark V. Clinical Dermatology. 4th Ed. Blackwell publishing. 2008, 248-252.
  23. WELLER, Richard P.J.B. HUNTER, John A.A. SAVIN, John A. and DAHL, Mark V. Clinical Dermatology. 4th Ed. Blackwell publishing. 2008, 248-252.
  24. WELLER, Richard P.J.B. HUNTER, John A.A. SAVIN, John A. and DAHL, Mark V. Clinical Dermatology. 4th Ed. Blackwell publishing. 2008, 248-252.
  25. WELLER, Richard P.J.B. HUNTER, John A.A. SAVIN, John A. and DAHL, Mark V. Clinical Dermatology. 4th Ed. Blackwell publishing. 2008, 248-252.
  26. WELLER, Richard P.J.B. HUNTER, John A.A. SAVIN, John A. and DAHL, Mark V. Clinical Dermatology. 4th Ed. Blackwell publishing. 2008, 248-252.